{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T08:16:06Z","timestamp":1776586566300,"version":"3.51.2"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,10]]},"DOI":"10.7759\/cureus.60035","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T13:51:29Z","timestamp":1715349089000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical and Demographic Characteristics of Pyruvate Kinase Deficiency Patients: A Comprehensive Case Series Analysis"],"prefix":"10.7759","author":[{"given":"Abdulrahman","family":"Nasiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfadil","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazzaa","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V19.3.267.267","article-title":"Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia","volume":"19","author":"Tanaka KR","year":"1962","unstructured":"Tanaka KR, Valentine WN, Miwa S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood. 1962, 19:267-95. 10.1182\/blood.V19.3.267.267","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V9.5.414.414","article-title":"Autohemolysis and other changes resulting from the incubation in vitro of red cells from patients with congenital hemolytic anemia","volume":"9","author":"Selwyn JG","year":"1954","unstructured":"Selwyn JG, Dacie JV. Autohemolysis and other changes resulting from the incubation in vitro of red cells from patients with congenital hemolytic anemia. Blood. 1954, 9:414-38. 10.1182\/blood.V9.5.414.414","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13424","article-title":"Prevalence of pyruvate kinase deficiency: a systematic literature review","volume":"105","author":"Secrest MH","year":"2020","unstructured":"Secrest MH, Storm M, Carrington C, Casso D, Gilroy K, Pladson L, Boscoe AN. Prevalence of pyruvate kinase deficiency: a systematic literature review. Eur J Haematol. 2020, 105:173-84. 10.1111\/ejh.13424","journal-title":"Eur J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000204890","article-title":"Erythrocyte pyruvate kinase deficiency in newborns of eastern Saudi Arabia","volume":"85","author":"Abu-Melha AM","year":"1991","unstructured":"Abu-Melha AM, Ahmed MA, Knox-Macaulay H, Al-Sowayan SA, El-Yahia A. Erythrocyte pyruvate kinase deficiency in newborns of eastern Saudi Arabia. Acta Haematol. 1991, 85:192-4. 10.1159\/000204890","journal-title":"Acta Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000153599","article-title":"Frequency of glucose-6-phosphate dehydrogenase, pyruvate kinase and hexokinase deficiency in the Saudi population","volume":"36","author":"El-Hazmi MA","year":"1986","unstructured":"El-Hazmi MA, Al-Swailem AR, Al-Faleh FZ, Warsy AS. Frequency of glucose-6-phosphate dehydrogenase, pyruvate kinase and hexokinase deficiency in the Saudi population. Hum Hered. 1986, 36:45-9. 10.1159\/000153599","journal-title":"Hum Hered"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/beha.1999.0057","article-title":"Red cell pyruvate kinase deficiency: from genetics to clinical manifestations","volume":"13","author":"Zanella A","year":"2000","unstructured":"Zanella A, Bianchi P. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Baillieres Best Pract Res Clin Haematol. 2000, 13:57-81. 10.1053\/beha.1999.0057","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.240846","article-title":"The variable manifestations of disease in pyruvate kinase deficiency and their management","volume":"105","author":"Al-Samkari H","year":"2020","unstructured":"Al-Samkari H, Van Beers EJ, Kuo KH, et al.. The variable manifestations of disease in pyruvate kinase deficiency and their management. Haematologica. 2020, 105:2229-39. 10.3324\/haematol.2019.240846","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20942","article-title":"Pyruvate kinase deficiency associated with severe liver dysfunction in the newborn","volume":"82","author":"Rapha\u00ebl MF","year":"2007","unstructured":"Rapha\u00ebl MF, Van Wijk R, Schweizer JJ, Schouten-van Meeteren NA, Kindermann A, van Solinge WW, Smiers FJ. Pyruvate kinase deficiency associated with severe liver dysfunction in the newborn. Am J Hematol. 2007, 82:1025-8. 10.1002\/ajh.20942","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-0834","article-title":"Cholestasis and hepatic failure in a neonate: a case report of severe pyruvate kinase deficiency","volume":"136","author":"Olivier F","year":"2015","unstructured":"Olivier F, Wieckowska A, Piedboeuf B, Alvarez F. Cholestasis and hepatic failure in a neonate: a case report of severe pyruvate kinase deficiency. Pediatrics. 2015, 136:e1366-8. 10.1542\/peds.2015-0834","journal-title":"Pediatrics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-810796","article-title":"Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study","volume":"131","author":"Grace RF","year":"2018","unstructured":"Grace RF, Bianchi P, van Beers EJ, et al.. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study. Blood. 2018, 131:2183-92. 10.1182\/blood-2017-10-810796","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24088","article-title":"Erythrocyte pyruvate kinase deficiency: 2015 status report","volume":"90","author":"Grace RF","year":"2015","unstructured":"Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B. Erythrocyte pyruvate kinase deficiency: 2015 status report. Am J Hematol. 2015, 90:825-30. 10.1002\/ajh.24088","journal-title":"Am J Hematol"},{"key":"ref12","article-title":"Pyruvate kinase deficient hemolytic anemia in an Amish isolate","volume":"17","author":"Bowman HS","year":"1965","unstructured":"Bowman HS, Mc Kusick VA, Dronamraju KR. Pyruvate kinase deficient hemolytic anemia in an Amish isolate. Am J Hum Genet. 1965, 17:1-8.","journal-title":"Am J Hum Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.196295","article-title":"Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study","volume":"104","author":"van Beers EJ","year":"2019","unstructured":"van Beers EJ, van Straaten S, Morton DH, et al.. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study. Haematologica. 2019, 104:e51-3. 10.3324\/haematol.2018.196295","journal-title":"Haematologica"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03849.x","article-title":"Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study","volume":"8","author":"Thomsen RW","year":"2010","unstructured":"Thomsen RW, Schoonen WM, Farkas DK, Riis A, Fryzek JP, S\u00f8rensen HT. Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study. J Thromb Haemost. 2010, 8:1413-6. 10.1111\/j.1538-7836.2010.03849.x","journal-title":"J Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13572","article-title":"Comorbidities and complications in adults with pyruvate kinase deficiency","volume":"106","author":"Boscoe AN","year":"2021","unstructured":"Boscoe AN, Yan Y, Hedgeman E, et al.. Comorbidities and complications in adults with pyruvate kinase deficiency. Eur J Haematol. 2021, 106:484-92. 10.1111\/ejh.13572","journal-title":"Eur J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000945","article-title":"Management of pyruvate kinase deficiency in children and adults","volume":"136","author":"Grace RF","year":"2020","unstructured":"Grace RF, Barcellini W. Management of pyruvate kinase deficiency in children and adults. Blood. 2020, 136:1241-9. 10.1182\/blood.2019000945","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228194-clinical-and-demographic-characteristics-of-pyruvate-kinase-deficiency-patients-a-comprehensive-case-series-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T13:51:32Z","timestamp":1715349092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228194-clinical-and-demographic-characteristics-of-pyruvate-kinase-deficiency-patients-a-comprehensive-case-series-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.60035","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,10]]}}}